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INTRODUCTION
Detailed study of 5.4.99.2) catalyzing the isomerization of methylmalonyl-CoA to succinyl-CoA, and 5-methyltetrahydrofolate:homocysteine methyltransferase (5-methyltetrahydropteroyl-L-glutamate:L-homocysteine S-methyltransferase, EC 2.1.1.13) which mediates the methylation of homocysteine to form methionine (4) . Previous investigations have shown that intact cbl C and cbl D fibroblasts are deficient in Cbl accumulation, in the synthesis of the two Cbl coenzymes, adenosylcobalamin (AdoCbl) and methylcobalamin (MeCbl), and accordingly in the holoenzyme activities of their respective apoenzymes, mutase and methyltransferase (2, (5) (6) (7) (8) . In 1975, a possible explanation for this pleiotropic phenotype was suggested by our observation that cbl C cells were unable to bind Cbl to an intra1Abbreviations used in this paper: AdoCbl, adenosylcobalamin; Cbl, cobalamin or vitamin B12; CN-Cbl, cyanocobalamin; MeCbl, methylcobalamin; MeFH4, N5-methyltetrahydrofolate; TC II, transcobalamin II. cellular protein(s) (9) . When crude extracts of control fibroblasts grown in medium that contained cyano-
[57Co]Cbl (CN-[57Co]Cbl) were chromatographed on Sephadex G-150, almost 90% ofthe label was found associated with a single protein peak ofan apparent mol wt of 120,000. On the other hand, cbl C cells treated in the same manner showed literally no such binding, although their initial uptake of CN-[57Co]Cbl from the medium appeared to be normal. Therefore, we postulated that a distinct Cbl-binding protein species, whose function might be to accumulate and retain intracellular Cbl for coenzyme synthesis, was deficient in cbl C fibroblasts.
More recently, however, we and others have obtained evidence suggesting that in rat (and rabbit) liver, virtually all intracellular Cbl is bound to the Cbldependent enzymes, mutase and methyltransferase (10, 11) . As a result of these findings, we have initiated a series of investigations designed to better understand the nature of intracellular Cbl binding in cultured human fibroblasts and to assess the significance of its absence in mutant cells.
The first of these reports is presented here. We have found that, as in rat liver, the (12) to allow its separation from radioactive contaminants in the commercial preparation. 1-ml fractions were collected and the OD at 280 nm was monitored. A major peak of absorbance, eluted after approximately 100 ml had been collected, contained >95% ofthe radioactivity. These fractions were pooled and concentrated iti the dark by lyophilization. MeFH4 was identified by its ultra-violet-visible absorbance spectra in 0. (5) . Cells were harvested 4 days after platinig with 0.25% trypsin/EDTA, centrifuged at 700g for 2.5 min, and washed twice with calcium-and magnesium-free Dulbecco's phosphate-buffered saline. Pellets were sonicate(l in 0.1 M potassium phosphate (pH 7.4) at 0°C using four 15-s bursts at 15-s intervals. Sonicates were centrifuged 10 min at 48,000 g and the supernate used for assay. In a final volume of 0.2 ml, the reaction inixture contained: 20 /-Lmol potassium phosphate (pH 7.4), 50 nmol S-adenosylmethionine, 25 Aitmol ,3-mercaptoethanol, 50 nmol L-homocysteine (prepared daily from the thiolactone), 10 nmol MeCbl, 50-100 nmol [14C]-MeFH4 (final sp act _2000 cpm/nmol), and 50-300 ,ug cell protein. Holoenzyme activity is defined as that activity which exists when the assay is conducted without added MeCbl; inclusion of MeCbl measures total (holoenzyme plus apoenzyme) activity. All procedures involving alkylcobalamiiins were carried out in the dark. Tubes were flushed with nitrogen and incubated at 37°C for 90 min. The reaction was terminated by the addition of 0.8 ml cold distilled water. [14C]Methionine was recovered by applying the reaction mixture to a Pasteur pipet column of Bio-Rad AG1-X8 resin (Bio-Rad Laboratories, Richmond, Calif.) (100-200 mesh, chloride form) ancd washing the column with an additional 1 ml of water. The 2 ml of effluent was pooled, 15 ml Aquasol (New Englanid Nuclear) was added, and radioactivity assayed in a Packard liquid scintillation spectrometer (Packard Instrument Co., Downers Grove, Ill.). Methyltransferase activity is expressed as picomoles methionine formed per minute per milligramii protein.
Protein was measured by the method of Lowry et al. (14) . Methylmaltnyl-CoA mutase assay. Mutase activity in cellfree extracts was determined by the production of [14C]succinate from [14C]methylmalonyl-CoA as described previously (15) . Total enzyme activity (holoenzyme plus apoenzyme) was measured by including 5 ,tM AdoCbl in the reaction mixture; holoenzyme activity was that which existed without added cofactor.
Intact cell assays. The activities of both mutase and methyltransferase were estimated in intact cells by measuring the activities of the overall metabolic pathways in which they function. Thus, the incorporation of 14C from [14C]propionate into acid-precipitable material (16) I'
and the plates incubated for 15 min at 4°C. After four additional washes with 5% TCA, the precipitate was dissolved in 0.2 M NaOH and assayed for protein (14) and radioactivity (16) . "Nonspecific" 14C incorporation, estimated by incubation of parallel samples in medium containing 0.1 mM methionine in the absence of homocysteine, was routinely subtracted. Gelfiltration. Columns of Sephadex G-150 (1.6 x 100 cm), equilibrated in 0.05 M potassium phosphate (pH 7.4) that contains 0.15 M NaCl, were standardized and run as described (9, 10) . Washed cell pellets were resuspended in 1-2 ml of column buffer, sonicated, and centrifuged at 48,000 g for 20 min before being applied to the column. Typically, over 75% of the cellular [57Co]Cbl was solubilized by this procedure.
Polyacrylamide gel electrophoresis. Both tube and slab gels (7 cm in length; 4% in acrylamide) were run without stacking gels according to the method of Davis (18) . Cell extracts were prepared by sonicating washed pellets in 0.02 M Tris/HCl (pH 7.4) at 0°C and centrifuging the sonicate at 105,000 g for 1 h. Gels were frozen, sliced into 1 mm-fractions, and mutase or methyltransferase activity determined by incubating slices in the appropriate reaction mixture in the presence of AdoCbl or MeCbl. 57Co was measured in each slice with a Packard Auto-Gamma spectrometer (Packard Instrument Co. (17) . The data in Table I show that, when measured in this way, the holo- (Table  II) . Whereas the fraction of total methyltransferase activity present as holoenzyme was less than 2.5% in cbl C cells, cbl D holomethyltransferase was found to be over 20%. Both ofthese values contrast with those from control-cell extracts, in which approximately 55% of total activity existed as holoenzyme. Total methyltransferase levels were also found to be generally lower in mutant cell extracts. These data are in close agreement with previous reports each of which examined only one or two cell lines (5, 6, 8, 19) . Similarly, mutase holoenzyme activity appeared to be affected more severely in cbl C-cell extracts (not detectable, <0.2%) than in cbl D extracts (0.5-1.0%). Control cells were found to contain between 3 and 8% holomutase under these growth conditions.
Characteristics of methyltransferase and mutase from mutant fibroblasts. The coordinate depression of both methyltransferase and mutase holoenzyme levels in cbl C and cbl D fibroblasts could result, theoretically, from an inability of the two apoenzymes to bind and retain Cbl as a result of a lesion affecting a shared subunit. Because such a defect might manifest itself as an alteration of the affinities of methyltransferase and mutase for their respective Cbl coenzymes, we measured these affinities in control and mutant cell extracts. As shown in Table III , neither mutase nor methyltransferase from cbl C or cbl D fibroblasts had Km's for their respective Cbl coenzymes which differed from those found in control cells. The affinity ofmethyltransferase for CN-Cbl was also determined because this Cbl species is almost as effective a cofactor as MeCbl (5) but must be methylated after binding to the enzyme (20) . The Km's obtained for CN-Cbl were identical to those for MeCbl (Table III) . However, it was found that CN-Cbl concentrations above 5 ,uM were inhibitory, an observation of interest because most other investigators have reported using CN-Cbl at 50 ,uM in vitro (5, (21) (22) (23) . No such inhibition was observed at concentrations of MeCbl up to 400 ,uM.
Since a mutation affecting a subunit common to both methyltransferase and mutase might not result in an alteration detectable in cell extracts as a Km difference, the electrophoretic mobility of Cbl-dependent enzyme activity from mutant cells was also determined. Extracts were prepared from cells grown in medium that contained 1 ,g/ml OH-Cbl to increase endogenous holoenzyme content, because it was found that only holomethyltransferase activity could be recovered from gel slices. As shown in Fig. 4 , no difference was observed in the electrophoretic profile of mutase and methyltransferase activity from cbl C's relative to that from controls. Similarly, data discussed above (Fig. 3) 4 Comparison of the electrophoretic mobilities of methylmalonyl-CoA mutase activity (A, A) and MeFH4:homocysteine methyltransferase activity (0, 0) from control and cbl C-fibroblast extracts. Gel slices were assayed in the presence of saturating amounts ofCbl (AdoCbl and MeCbl, respectively). However, omission of MeCbl from the reaction mixture was found not to decrease the methyltransferase activity detected, indicating that only holomethyltransferase activity could be recovered after electrophoresis. As (Table II and [5, 6, and 19] ), the possibility must be considered that a primary defect of this enzyme alone might result in such a phenotype. To explain the low levels ofAdoCbl and mutase holoenzyme in these cells, however, binding to methyltransferase must then be presumed to be an obligatory intermediate step between the uptake of Cbl from the medium and its entry into the mitochondrion, the subcellular site of both AdoCbl synthesis and mutase activity (2, 10, (25) (26) (27) . Although there is some kinetic evidence from rat liver which suggests that [57Co]Cbl is bound to methyltransferase before mutase (10) , preliminary results using cultured fibroblasts appear to have indicated otherwise.3 In addition, it has been possible to demonstrate directly the ability of cbl C methyltransferase to bind [57Co]Cbl in somatic cell hybrids formed from the fusion of cbl C and mouse fibroblasts.4
Because the endo-lysosomal system which mediates the specific uptake ofTC II-bound Cbl has been shown to be normal in both cbl C and cbl D fibroblasts (28),3 the most likely alternative possibility is that these mutations affect some enzymatic step(s) responsible for the metabolic conversion of [57Co]Cbl to a form which allows its binding to both apoenzymes. In that these cells are also deficient in the formation of Cbl coenzymes, it is probable that such a step occurs early in the intracellular metabolism of Cbl at a point common to the pathways of both MeCbl and AdoCbl biosynthesis. Little is known concerning these early events thus making it difficult to speculate further. However, it is 4 Mellman, I., P-f. Lin, F. H. Ruddle, and L. E. Rosenberg.
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believed that Cbl, which enters the cell with its cobalt nucleus in an oxidation state of plus III (cob[III]-alamin), must undergo a stepwise reduction to cob(I)alamin before it is available as a substrate for coenzyme synthesis (29) . Thus, these mutations might affect enzymes related to cob(III)alamin reductase activity.
Finally, the data presented in this paper demonstrate that cbl D fibroblasts can be distinguished biochemically from cbl C fibroblasts, as well as by genetic complementation analysis (3). While cells from both groups were found to be deficient in intracellular [57Co] Cbl binding and in the holoenzyme activities of both methyltransferase and mutase, cbl D fibroblasts were generally less severely affected relative to controls. The two brothers originally described by Goodman et al. (19) are thus far the only patients we have ascertained whose fibroblasts fall into the cbl D group. Whereas they are likewise less severely affected clinically compared to some of the patients expressing the cbl C mutation (5, 8, 30) , the small number of cases involved precludes any general statement. None of the data obtained thus far, however, necessarily indicate that cbl C and cbl D fibroblasts express mutations affecting Cbl metabolism at distinct genetic loci, because in some cases complementation between mutant cell lines may occur as a result of interallelic (31) , as opposed to intergenic (32) events. Indeed, both the clinical and cellular phenotypes associated with the cbl D mutation might also be associated with a "leaky" cbl C mutation. Resolution of this question must await the elucidation of the underlying biochemical defect in at least one of these two groups.
